Tri(n‐Butyl) Phosphate/Detergent Treatment of Licensed Therapeutic and Experimental Blood Derivatives1
- 5 March 1987
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 52 (1-2), 53-59
- https://doi.org/10.1111/j.1423-0410.1987.tb02989.x
Abstract
Incubation of an AHF concentrate with 0.3% tri(n-butyl)phosphate (TNBP) and 0.2% sodium cholate was shown to inactivate at least 10,000 infectious doses of lipid-enveloped viruses, including hepatitis B and non-A, non-B viruses and HTLV-III [Prince et al., Lancet i, pp. 706–710, 1986]. The use of TNBP/detergent combinations for virus sterilization was evaluated further to determine its effect on the structure and function of a wide variety of blood proteins. Vesicular stormatitis and Sindbis viruses were used as markers of virus inactivation. TNBP/detergent treatment did not significantly alter the function of AHF, factor VII, factor IX, factor X, fibrinogen, factor XIII, fibronectin, anti-HBsAg and anti-HA in normal immune serum globulin, haptoglobin, tumor necrosis factor, α-interferon, and both native and chemically polymerized stroma-free hemoglobin. As compared with partially purified derivatives, the extent of virus sterilization of plasma and component cryoprecipitate with 0.3% TNBP and 0.2% sodium cholate at ambient temperature could be improved by raising the TNBP concentration and temperature. Virus sterilization by TNBP/detergent mixtures appears to be generally applicable to blood protein derivatives.This publication has 32 references indexed in Scilit:
- STERILISATION OF HEPATITIS AND HTLV-III VIRUSES BY EXPOSURE TO TRI(n-BUTYL)PHOSPHATE AND SODIUM CHOLATEThe Lancet, 1986
- Effect of Cohn Fractionation Conditions on Infectivity of the AIDS VirusNew England Journal of Medicine, 1986
- Inactivation of viruses in labile blood derivatives. I. Disruption of lipid‐enveloped viruses by tri(n‐butyl)phosphate detergent combinationsTransfusion, 1985
- WET HEATING FOR SAFER FACTOR VIII CONCENTRATE?The Lancet, 1985
- NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULINThe Lancet, 1985
- Preparation of antihemophilic factor and fibronectin from human plasma cryoprecipitateTransfusion, 1984
- NON-A, NON-B HEPATITIS FROM INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1983
- Plasma derivatives and viral hepatitisTransfusion, 1982
- Stability of Immune Serum Globulin During Storage: Effects of Modifications in the Fractionation SchemeVox Sanguinis, 1969
- The Separation of the Antibodies, Isoagglutinins, Prothrombin, Plasminogen and β1-Lipoprotein into Subfractions of Human PlasmaJournal of the American Chemical Society, 1949